Thinking About Trying Compounded Semaglutide
In addition to its glucose-lowering and weight-loss effects, tirzepatide is currently undergoing Phase 3 or 4 clinical trials for other conditions, including obesity with osteoarthritis, atherosclerosis in T2DM patients, lipid metabolism and brain function in T2DM patients, and obstructive sleep apnea
This protective effect was primarily driven by a 30% reduction in liver decompensation events, comprising ascites, hepatic encephalopathy, variceal bleeding, and hepatorenal syndrome (IRR: 0.70, 95%CI: 0.52-0.94, P = 0.020), based on six studies comprising 877,488 participants
Loren Pickart about a copper peptide that reversed aging in human fibroblasts